14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 03, 2024 $4.96 $5.09 $4.68 $4.71 144 595
Apr 02, 2024 $4.97 $5.05 $4.79 $4.94 136 502
Apr 01, 2024 $4.65 $5.00 $4.60 $4.88 126 407
Mar 28, 2024 $4.62 $4.65 $4.50 $4.65 113 100
Mar 27, 2024 $4.87 $4.87 $4.40 $4.59 149 728
Mar 26, 2024 $4.97 $5.00 $4.64 $4.69 102 444
Mar 25, 2024 $4.80 $5.13 $4.68 $4.90 271 389
Mar 22, 2024 $4.61 $4.95 $4.54 $4.86 267 361
Mar 21, 2024 $4.40 $4.66 $3.99 $4.66 651 481
Mar 20, 2024 $5.51 $5.66 $4.34 $4.44 687 294
Mar 19, 2024 $5.52 $5.84 $5.36 $5.37 227 730
Mar 18, 2024 $5.50 $5.73 $5.50 $5.52 123 551
Mar 15, 2024 $4.97 $5.53 $4.80 $5.42 190 663
Mar 14, 2024 $5.52 $5.52 $4.93 $5.03 162 739
Mar 13, 2024 $5.59 $5.76 $5.57 $5.64 127 044
Mar 12, 2024 $5.85 $5.97 $5.35 $5.53 221 233
Mar 11, 2024 $6.01 $6.38 $5.76 $5.77 164 070
Mar 08, 2024 $6.16 $6.55 $6.16 $6.35 119 016
Mar 07, 2024 $6.42 $6.63 $6.16 $6.37 138 887
Mar 06, 2024 $6.34 $6.57 $6.27 $6.40 101 276
Mar 05, 2024 $6.27 $6.49 $6.26 $6.32 85 737
Mar 04, 2024 $6.87 $7.22 $6.27 $6.35 245 814
Mar 01, 2024 $6.20 $6.87 $6.12 $6.80 512 054
Feb 29, 2024 $6.14 $6.25 $5.98 $6.13 110 307
Feb 28, 2024 $5.95 $6.38 $5.93 $6.14 161 126
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT